Question 1

What is the catalog number for SgRNA control lentivirus (Puro) - sgRNA control lentivirus (Puro)?

Accepted Answer

The catalog number for SgRNA control lentivirus (Puro) - sgRNA control lentivirus (Puro) is HKO-LV-control-100.

Question 2

What sizes are available for SgRNA control lentivirus (Puro) - sgRNA control lentivirus (Puro)?

Accepted Answer

SgRNA control lentivirus (Puro) - sgRNA control lentivirus (Puro) is available in the following size(s): 1 Vial.

Question 3

Is SgRNA control lentivirus (Puro) - sgRNA control lentivirus (Puro) in stock?

Accepted Answer

SgRNA control lentivirus (Puro) - sgRNA control lentivirus (Puro) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is SgRNA control lentivirus (Puro) - sgRNA control lentivirus (Puro) used for?

Accepted Answer

100 µL (4 x 25 µL)

Question 5

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Question 6

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 7

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

SgRNA control lentivirus (Puro) - sgRNA control lentivirus (Puro)

Product Specifications

Frequently Asked Questions

Explore Other Products

Giardia lamblia (BB1.1E5), 1mg/mL

Anti-RBM42 Antibody Picoband®, Carrier-free

Anti-GLUT9/SLC2A9 Antibody Picoband®

HLA-DR (MHC II) (TAL 1B5), CF740 conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF568 conjugate, 0.1mg/mL

GnRH-Receptor (LHRH Receptor) (F1G4), CF405S conjugate, 0.1mg/mL